Moxiget of Getz Pharma (Private) Ltd Approved by (WHO)
Moxiget (Moxifloxacin Hydrochloride) 400mg tablets and injectable produced by Getz Pharma (Private) Ltd Karachi, has become the first Pakistani medicine to be added to the list of pre-qualified products (those medicines that have been evaluated by WHO and are considered up to the mark for procurement by UN agencies, other international agencies and countries). Furthermore after a comprehensive inspection the WHO team has also found the companyâ€™s Quality Control Laboratory to be complying with Good Practices as prescribed by WHO.
This means that now Moxiget will be easily exported anywhere in the world. This will prove to be a big boost to Pakistanâ€™s drug exports which is currently only $110 million annually.
Moxiget is used to treat various kinds ofbacterial infections of the lungs, sinuses, skin and stomach.
About Getz Pharma (Private) Ltd
The company operates in over 23 countries situated in Africa, Central Asia, Middle East and South East Asia, and in most of them is one of the fastest growing medical organizations.
In Pakistan; since its initiation in 1995, it has progressed tremendously and today it occupies 3rdÂ place among more than 600 medical companies in the country. It is also Pakistanâ€™s biggest branded generic pharmaceutical company.
It manufactures over a wide array of medicines, many of which are leading products in their categories. It is the largest exporter in Pakistan, and supplies to countries such as Afghanistan, Cambodia, Hong Kong, Kazakhstan, Kenya, Laos, Malaysia, Mauritius, Myanmar, Nigeria, Philippines, Sri Lanka, Sudan, Tajikstan, Vietnam and Yemen. Plans of exporting to 30 other countries is expected in near future.
Over the years, based on its performance it has received many awards specifically theÂ Federation of Pakistan Chambers Of Commerce & IndustryÂ (FPCCI)â€™s Best Export Performance Award for the past 12 consecutive years!